286 related articles for article (PubMed ID: 30305678)
1. Neck Lymph Node Metastasis as A Poor Prognostic Factor in Thoracic Esophageal Squamous Cell Carcinoma Patients Receiving Concurrent Chemoradiotherapy: A Propensity Score-Matched Analysis.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Shih LH; Chen SW; Li SH
Sci Rep; 2018 Oct; 8(1):15073. PubMed ID: 30305678
[TBL] [Abstract][Full Text] [Related]
2. Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery.
Cho WK; Oh D; Ahn YC; Shim YM; Zo JI; Sun JM; Ahn MJ; Park K
Oncotarget; 2017 Jan; 8(2):3542-3552. PubMed ID: 27682879
[TBL] [Abstract][Full Text] [Related]
3. Induction immunotherapy plus chemotherapy followed by definitive chemoradiation therapy in locally advanced esophageal squamous cell carcinoma: a propensity-score matched study.
Lian HM; Wu JL; Liufu WJ; Yu TT; Niu SQ; Bao Y; Peng F
Cancer Immunol Immunother; 2024 Feb; 73(3):55. PubMed ID: 38366287
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of celiac lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Wang YM; Lo CM; Chou SY; Huang CH; Shih LH; Chen SW; Li SH
Oncotarget; 2017 Nov; 8(56):96190-96202. PubMed ID: 29221198
[TBL] [Abstract][Full Text] [Related]
5. The clinical impact of supraclavicular lymph node metastasis in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Huang CH; Shih LH; Chen SW; Li SH
PLoS One; 2018; 13(6):e0198800. PubMed ID: 29889869
[TBL] [Abstract][Full Text] [Related]
6. The role of postoperative adjuvant chemotherapy for lymph node-positive esophageal squamous cell carcinoma: a propensity score matching analysis.
Qin RQ; Wen YS; Wang WP; Xi KX; Yu XY; Zhang LJ
Med Oncol; 2016 Apr; 33(4):31. PubMed ID: 26922662
[TBL] [Abstract][Full Text] [Related]
7. Treatment Outcomes of Patients with Locally Advanced Synchronous Esophageal and Head/Neck Squamous Cell Carcinoma Receiving Curative Concurrent Chemoradiotherapy.
Chen YH; Lu HI; Chien CY; Lo CM; Wang YM; Chou SY; Su YY; Shih LH; Li SH
Sci Rep; 2017 Jan; 7():41785. PubMed ID: 28134308
[TBL] [Abstract][Full Text] [Related]
8. [Patterns of recurrence in patients with stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy].
Wang Y; Wang L; Yang Q; Li J; He M; Yao J; Qi Z; Li B; Qiao X
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):48-54. PubMed ID: 26796807
[TBL] [Abstract][Full Text] [Related]
9. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
[TBL] [Abstract][Full Text] [Related]
10. Cervical lymph node metastasis classified as regional nodal staging in thoracic esophageal squamous cell carcinoma after radical esophagectomy and three-field lymph node dissection.
Chen J; Wu S; Zheng X; Pan J; Zhu K; Chen Y; Li J; Liao L; Lin Y; Liao Z
BMC Surg; 2014 Dec; 14():110. PubMed ID: 25527100
[TBL] [Abstract][Full Text] [Related]
11. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
12. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
13. Regional hyperthermia combined with radiotherapy for esophageal squamous cell carcinoma with supraclavicular lymph node metastasis.
Sheng L; Ji Y; Wu Q; Du X
Oncotarget; 2017 Jan; 8(3):5339-5348. PubMed ID: 28029663
[TBL] [Abstract][Full Text] [Related]
14. Analysis of definitive chemo-radiotherapy for esophageal cancer with supra-clavicular node metastasis based on CT in a single institutional retrospective study: a propensity score matching analysis.
Xu HY; Wu SX; Luo HS; Chen CY; Lin LX; Huang HC
Radiat Oncol; 2018 Oct; 13(1):200. PubMed ID: 30326912
[TBL] [Abstract][Full Text] [Related]
15. Different prognosis of patients with esophageal carcinoma with M1a and regional node involvement.
Chung TR; Kim JH; Lee IJ; Cho Y; Kim JW; Lee CG; Jung DH; Park JJ; Youn YH; Park H
Dig Liver Dis; 2019 Nov; 51(11):1610-1616. PubMed ID: 31175014
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of lymph node metastases and lymph node ratio in esophageal squamous cell carcinoma.
Liu YP; Ma L; Wang SJ; Chen YN; Wu GX; Han M; Wang XL
Eur J Surg Oncol; 2010 Feb; 36(2):155-9. PubMed ID: 19854606
[TBL] [Abstract][Full Text] [Related]
17. The crucial role of blood VEGF kinetics in patients with locally advanced esophageal squamous cell carcinoma receiving curative concurrent chemoradiotherapy.
Chen YH; Lu HI; Lo CM; Wang YM; Chou SY; Hsiao CC; Huang CC; Shih LH; Chen SW; Li SH
BMC Cancer; 2018 Aug; 18(1):837. PubMed ID: 30126380
[TBL] [Abstract][Full Text] [Related]
18. Involved-field chemoradiotherapy for postoperative solitary lymph node recurrence of esophageal cancer.
Kawamoto T; Nihei K; Sasai K; Karasawa K
Esophagus; 2018 Oct; 15(4):256-262. PubMed ID: 30225742
[TBL] [Abstract][Full Text] [Related]
19. The Prognostic Impact of Lymph Node Involvement in Large Scale Operable Node-Positive Esophageal Squamous Cell Carcinoma Patients: A 10-Year Experience.
Xu XL; Zheng WH; Zhu SM; Zhao A; Mao WM
PLoS One; 2015; 10(7):e0133076. PubMed ID: 26177369
[TBL] [Abstract][Full Text] [Related]
20. Safety and oncological efficacy of bilateral recurrent laryngeal nerve lymph-node dissection after neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma: a propensity-matched analysis.
Chao YK; Chiu CH; Liu YH
Esophagus; 2020 Jan; 17(1):33-40. PubMed ID: 31428901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
